Status:
COMPLETED
Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Advanced Lung Carcinoma
Malignant Female Reproductive System Neoplasm
Eligibility:
All Genders
Phase:
NA
Brief Summary
This trial will pilot a psychosocial intervention called Conquer Fear Support (CFS) in patients with stage III-IV lung or gynecologic cancer who are experiencing fear of cancer progression. The interv...
Detailed Description
PRIMARY OBJECTIVES: I. Assess the feasibility and acceptability of the CFS intervention in patients with advanced lung and gynecologic (GYN) cancer (stages III or IV) who have clinically significant ...
Eligibility Criteria
Inclusion
- Patients with gynecologic (GYN) and lung cancer will be recruited
- Stage III or IV disease
- At least 3 months from initial diagnosis
- Receiving disease-focused treatment or active surveillance mode
- A score of ≥ 34 on the Fear of Progression Questionnaire-Short Form (SF) or ≥ 24 on the Impact of Event Scale-Revised
- All subjects must have the ability to understand and the willingness to sign a written informed consent
Exclusion
- Current severe depression or psychosis; significant cognitive impairment
- Patients enrolled in hospice care or who opt to receive no further disease-focused treatment
- Patients who are currently receiving ongoing psychiatric treatment
- Non-English speaking
Key Trial Info
Start Date :
November 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 26 2024
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03776253
Start Date
November 15 2018
End Date
August 26 2024
Last Update
January 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010